References

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV

10.1016/j.radonc.2004.12.015 · 2005 · External reference

Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology

10.1016/j.radonc.2005.11.014 · 2006 · External reference

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy

10.1016/j.radonc.2010.06.004 · 2010 · External reference

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy

10.1016/j.radonc.2011.12.024 · 2012 · External reference

Implementation of Image-guided Brachytherapy for Cervix Cancer in the UK: progress Update

10.1016/j.clon.2011.07.011 · 2011 · External reference

Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society

10.1016/j.ijrobp.2015.11.024 · 2016 · External reference

10.1097/igc.0b013e31821caa55

10.1097/igc.0b013e31821caa55 · 2011 · External reference

Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience

10.1016/j.ygyno.2013.04.018 · 2013 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer

10.1016/j.radonc.2011.07.012 · 2011 · External reference

MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective

10.3109/0284186x.2013.818253 · 2013 · External reference

Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients

10.1016/j.radonc.2016.04.016 · 2016 · External reference

Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience

10.1016/j.radonc.2013.04.006 · 2013 · External reference

MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience

10.1016/j.ijrobp.2014.10.053 · 2015 · External reference

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

10.1016/j.ygyno.2014.08.027 · 2014 · External reference

Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study

10.1016/j.radonc.2012.04.007 · 2012 · External reference

Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes

10.1016/j.ijrobp.2015.04.018 · 2015 · External reference

Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer

10.1016/j.ygyno.2015.09.008 · 2015 · External reference

Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: an experience from a tertiary cancer centre in a low-middle income country setting

10.1016/j.ijrobp.2017.06.010 · 2017 · External reference

Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study

10.1016/j.radonc.2016.03.011 · 2016 · External reference

Bowel morbidity in cervix cancer after RCHT+IGABT; physician and patient reported outcome - EMBRACE

10.1016/s0167-8140(17)30500-5 · 2017 · External reference

Physician assessed and patient reported bladder morbidity after RCHT and IGABT for cervical cancer

10.1016/s0167-8140(17)30496-6 · 2017 · External reference

3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control

10.1016/j.radonc.2010.10.002 · 2010 · External reference

Fatigue, insomnia, hot flashes (CTCAE) after definitive RCHT+IGABT for cervical cancer (EMBRACE)

10.1016/s0167-8140(17)30495-4 · 2017 · External reference

Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept

10.1016/j.brachy.2016.08.009 · 2016 · External reference

Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study

10.1016/j.ijrobp.2015.12.363 · 2016 · External reference

Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study

10.1016/j.radonc.2013.01.014 · 2013 · External reference

Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy

10.1016/j.radonc.2012.12.017 · 2013 · External reference

Image Guided Adaptive Brachytherapy in cervix cancer: a new paradigm changing clinical practice and outcome

10.1016/j.radonc.2016.08.007 · 2016 · External reference

Local failures after radiochemotherapy and MR-image-guided brachytherapy in cervical cancer patients

10.1016/s0167-8140(17)30499-1 · 2017 · External reference

Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer

10.1016/j.radonc.2016.05.014 · 2016 · External reference

Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study

10.1016/j.radonc.2016.03.020 · 2016 · External reference

Image guided brachytherapy in cervical cancer: a comparison between intracavitary and combined intracavitary/interstitial brachytherapy in regard to doses to HR CTV, OARs and late morbidity – early results from the embrace study in 999 patients

10.1016/j.brachy.2016.04.010 · 2016 · External reference

Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study

10.1016/j.ijrobp.2014.01.032 · 2014 · External reference

Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study

10.1016/j.radonc.2015.12.025 · 2016 · External reference

Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer

10.1016/j.radonc.2016.05.020 · 2016 · External reference

Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy

10.1016/j.radonc.2013.04.009 · 2013 · External reference

Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients

10.1016/j.radonc.2016.05.002 · 2016 · External reference

Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study

10.1016/j.radonc.2016.06.006 · 2016 · External reference

Dose Effect Relationship for Late Side Effects of the Rectum and Urinary Bladder in Magnetic Resonance Image-Guided Adaptive Cervix Cancer Brachytherapy

10.1016/j.ijrobp.2010.12.029 · 2012 · External reference

Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy

10.1016/j.ijrobp.2007.02.009 · 2007 · External reference

Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: dose-volume effect relationships for the rectum and bladder

10.1016/j.radonc.2015.06.027 · 2015 · External reference

Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity

10.1016/j.brachy.2015.08.007 · 2015 · External reference

Intermediate dose–volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer

10.1016/j.brachy.2017.06.007 · 2017 · External reference

Tolerance of the Small Bowel to Therapeutic Irradiation

10.1097/igc.0b013e318286aa68 · 2013 · External reference

10.3109/0284186x.2014.928418

10.3109/0284186x.2014.928418 · External reference

The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma

10.1016/0167-8140(94)90097-3 · 1994 · External reference

Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: a randomized prospective study

10.1016/j.canrad.2016.05.011 · 2016 · External reference

Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study

10.1016/j.ijrobp.2013.06.2059 · 2013 · External reference

Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy

10.1016/s0360-3016(03)00325-0 · 2003 · External reference

Phase III RCT of Postoperative Adjuvant Conventional Radiation (3DCRT) Versus IGIMRT for Reducing Late Bowel Toxicity in Cervical Cancer (PARCER) (NCT01279135/CTRI2012/120349): results of Interim Analyses

10.1016/j.ijrobp.2015.07.016 · 2015 · External reference

A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy

10.1016/j.ijrobp.2016.06.024 · 2016 · External reference

Unresolved reference

External reference

10.1002/14651858.cd002225.pub2

10.1002/14651858.cd002225.pub2 · External reference

Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy

10.1016/j.ygyno.2014.02.004 · 2014 · External reference

Distant metastases in locally advanced cervical cancer pattern of relapse and prognostic factors: early results from the EMBRACE study

10.1016/j.ijrobp.2015.07.026 · 2015 · External reference

Nodal failure after chemoradiation and magnetic resonance imaging guided adaptive BT in cervical cancer: a subanalysis within embrace

10.1016/j.ijrobp.2016.06.044 · 2016 · External reference

Patterns of regional recurrence after definitive radiotherapy for cervical cancer

10.1016/j.ijrobp.2009.04.009 · 2010 · External reference

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results

10.1016/j.ijrobp.2006.04.041 · 2006 · External reference

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results

10.1016/j.ijrobp.2006.01.036 · 2006 · External reference

Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component

10.1016/j.radonc.2013.01.010 · 2013 · External reference

Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicen

10.1016/j.brachy.2012.11.001 · 2013 · External reference

Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: final results of the EMBRACE study dummy run

10.1016/j.radonc.2015.08.001 · 2015 · External reference

Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer

10.1016/j.radonc.2012.08.012 · 2012 · External reference

Importance of technique, dose prescription, and contouring in cervix external beam radiation therapy: current and future practice in a large multicenter study (EMBRACE)

10.1016/j.ijrobp.2016.06.1359 · 2016 · External reference

Early clinical outcome of coverage probability based treatment planning in locally advanced cervical cancer for simultaneous integrated boost of nodes

10.1080/0284186x.2017.1349335 · 2017 · External reference

Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer

10.3109/0284186x.2015.1061693 · 2015 · External reference

Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer

10.1002/cncr.24972 · 2010 · External reference

Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy

10.1097/igc.0000000000000772 · 2016 · External reference

The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy

10.1016/j.radonc.2013.04.015 · 2013 · External reference

Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era

10.1016/j.ijrobp.2014.08.013 · 2014 · External reference

Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer

10.1016/j.radonc.2017.01.015 · 2017 · External reference

Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI

10.1158/0008-5472.can-12-1085 · 2012 · External reference

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study

10.1038/bjc.2016.340 · 2016 · External reference

From prospective biobanking to precision medicine: BIO-RAIDs – an EU study protocol in cervical cancer

10.1186/s12885-015-1801-0 · 2015 · External reference

Income generated by women treated with magnetic resonance imaging-based brachytherapy: a simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting

10.1016/j.brachy.2017.05.003 · 2017 · External reference

The MRI-linear accelerator consortium: evidence-based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance, and technical development

10.3389/fonc.2016.00215 · 2016 · External reference

Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer

10.3109/0284186x.2016.1139179 · 2016 · External reference

Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704)

10.1002/cncr.28621 · 2014 · External reference

Dose–escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902)

10.1016/j.ygyno.2013.10.021 · 2014 · External reference

Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach

10.1016/j.radonc.2013.05.007 · 2013 · External reference

The quest for evidence for proton therapy: model-based approach and precision medicine

10.1016/j.ijrobp.2015.10.004 · 2016 · External reference

Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer

10.1016/j.radonc.2015.10.007 · 2015 · External reference

The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy

10.1016/j.radonc.2016.04.028 · 2016 · External reference

Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): objectives and priorities

10.1016/j.radonc.2015.09.012 · 2015 · External reference

Perspectives on medical education in radiation oncology and the role of the ESTRO School

2016 · External reference

Implementatie en “quality assurance” van “state-of-the-art” radiotherapie voor gevorderd cervixcarcinoom in Nederland: een kwaliteitsbevorderingsproject

2017 · External reference